Of note, NF-L has turned into focus of stroke research, as recent clinical studies demonstrated a correlation between peripheral serum NF-L levels and the infarct volume [26–29], as well as the functional outcome and mortality of stroke patients [27, 30–35], effectively promoting NF-L as a diagnostic and prognostic biomarker. The gene discussed is NEFL; the disease is Stroke.